Most chemotherapeutic drugs are potent and have a very narrow range of dose safety and efficacy, most of which can cause many side effects.
Chemotherapy-induced
peripheral neuropathy (CIPN) is the most common and serious side effect of
chemotherapy for
cancer treatment. However, its mechanism of action is yet to be fully elucidated. In the present study, we found that the treatment of the
chemotherapy drug
elemene induced
hyperalgesia accompanied by anxiety-like emotions in mice based on several
pain behavioral assays, such as
mechanical allodynia and
thermal hyperalgesia tests. Second, immunostaining for c-fos (a marker of activated neurons) further showed that
elemene treatment activated several brain regions, including the lateral septum (LS), cingulate cortex (ACC), paraventricular nucleus of the thalamus (PVT), and dorsomedial hypothalamic nucleus (
DMH), most notably in the GABAergic neurons of the lateral septum (LS). Finally, we found that both chemogenetic inhibition and apoptosis of LS neurons significantly reduced
pain- and anxiety-like behaviors in mice treated with
elemene. Taken together, these findings suggest that LS is involved in the regulation of
elemene-induced
chemotherapy pain and anxiety-like behaviors, providing a new target for the treatment of
chemotherapy pain induced by
elemene.